<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SII-32391</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Concord Medical</narrative>
  </title>
  <description type="2">
   <narrative xml:lang="EN">1. Increase access to quality healthcare services. The Project will support an established healthcare service provider to move down-market to frontier provinces, to reach middle- and lower-income households, providing affordable basic radiotherapy services that are not readily available to those populations.  2. Enable knowledge transfer. Successful operation of the Proton Beam, one of the most advanced technologues in radiotherapy, would enable knowledge transfer amongst radiotherapy practitioners both within and outside the Company  3. Demonstration effect. This will be achieved in terms of improving standards and corporate governance in healthcare management, and in sending a positive message to other private sector investors about potential market opportunities in the healthcare sector.  4. Promoting health care reform and the public private partnership model. Concord&apos;&apos;s success should help to enhance China&apos;&apos;s health authorities&apos;&apos; confidence in private health care providers and increase willingness to further relax the regulatory barriers for private investment in the sector.   5. Create skilled employment opportunities. The Project will provide training and create employment opportunities for a number of specialty healthcare positions, including those of radiologists, which are currently in short supply in China.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">Concord Medical Services Holdings Limited (Concord or the Company), which is listed on the New York Stock Exchange, has 133 centers located in 52 cities across 25 provinces. The Company operates the largest network of radiotherapy and diagnostic imaging centers in China. The Company also acquired a 52% interest in Changan Hospital, a private hospital in Xian, Shaanxi province, in the second quarter of 2012. Over the next three years, Concord will further expand its network by opening 50 new oncology and diagnostic centers, invest in a proton center in Beijing, and invest in an oncology hospital in Guangzhou (together, the Project).</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Concord Medical Services Holdings Limited</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SII-32391" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2013-05-14" type="1"></activity-date>
  <activity-date iso-date="2014-02-18" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">(i) Concord Medical Services Holdings Limited 18/F, Tower A, Global Trade Center 36 North Third Ring Road, Dongcheng District Beijing 100013 Peoples Republic of China  (ii) International Finance Corporation 14/F One Pacific Place 88 Queensway, Admiralty Hong Kong</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Mr. Adam J. Sun, Chief Financial Officer Concord Medical Services Holdings Limited Tel: 86-10-5903-6688 Fax: 86-10-5957-5255 Address: 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dong Cheng District, Beijing 100013  http://www.concordmedical.com</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="CN" percentage="100">
   <narrative xml:lang="EN">China</narrative>
  </recipient-country>
  <location ref="CN-China">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">The 50 new oncology and diagnostic centers will be opened primarily in frontier provinces. Concord is currently in discussions with potential hospital partners in frontier provinces such as Sichuan, Henan and Anhui. The proton center will be opened in Beijing. The oncology hospital will be opened in Guangzhou.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>35.0000000000 105.0000000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector code="6215" percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">S-AB - Medical and Diagnostic Services</narrative>
  </sector>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $50.00 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="411"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2013-05-14"></period-start>
   <period-end iso-date="2013-06-30"></period-end>
   <value currency="USD" value-date="2013-05-14">50000000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2013-05-14"></transaction-date>
   <value currency="USD" value-date="2013-05-14">50000000</value>
   <receiver-org>
    <narrative xml:lang="EN">Concord Medical Services Holdings Limited</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="411"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SII/32391/concord-medical">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information - Anticipated Impact Measurement &amp; Monitoring (AIMM) Assessment and Main Environmental &amp; Social Risks and Impacts of the Project</narrative>
   </title>
   <category code="A01"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SII/32391/concord-medical">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
